Get to know Aduhelm better with 5 real example sentences.
Aduhelm in a sentence
Context around Aduhelm
- Average sentence length in these examples: 19 words
- Position in the sentence: 2 start, 0 middle, 3 end
- Sentence types: 4 statements, 1 questions, 0 exclamations
Corpus analysis for Aduhelm
- In this selection, "aduhelm" usually appears near the end of the sentence. The average example has 19 words, and this corpus slice is mostly made up of statements.
- Around the word, monthly, prescribe, flopped, infusions and soon stand out and add context to how "aduhelm" is used.
- Recognizable usage signals include homepage of aduhelm soon after and like aduhelm s label. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "aduhelm" sits close to words such as aaas, aacc and aacs, which helps place it inside the broader word index.
Example types with aduhelm
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Can Leqembi Succeed Where Aduhelm Flopped? (6 words)
While prescriptions of Leqembi are now taking off, doctors have hesitated to prescribe Aduhelm. (14 words)
The homepage of Aduhelm, soon after the drug won accelerated approval from the FDA in June 2021. (17 words)
Like Aduhelm’s label, Leqembi’s includes warnings about brain swelling and brain bleeding and notes that patients with a gene mutation that increases the risk of developing Alzheimer’s have a greater risk of brain swelling with the treatment. (40 words)
Pat, 75, was diagnosed with the disease in October 2021 and started on monthly Aduhelm infusions shortly after. (18 words)
The homepage of Aduhelm, soon after the drug won accelerated approval from the FDA in June 2021. (17 words)
Can Leqembi Succeed Where Aduhelm Flopped? (6 words)
Example sentences (5)
Can Leqembi Succeed Where Aduhelm Flopped?
Like Aduhelm’s label, Leqembi’s includes warnings about brain swelling and brain bleeding and notes that patients with a gene mutation that increases the risk of developing Alzheimer’s have a greater risk of brain swelling with the treatment.
Pat, 75, was diagnosed with the disease in October 2021 and started on monthly Aduhelm infusions shortly after.
The homepage of Aduhelm, soon after the drug won accelerated approval from the FDA in June 2021.
While prescriptions of Leqembi are now taking off, doctors have hesitated to prescribe Aduhelm.